glp-1 news nov 2025 Coverage for some popular medications is set to go away in January Myths & Facts: GLP-1 Drugs

Abstract Accumulating evidence supports the early use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium glucose transporter-2 inhibitors (SGLT-2is) for the treatment of type 2 diabetes

Promoted alongside its microdosed GLP-1 program, Noom says the pairing kickstarts the action-motivation flywheel. On track

Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization

Does the supplier publish batch-specific COAs

Best of all, Ro offers new patients ongoing support and a $50 credit with their results, helping them navigate their weight loss program from start to finish